Main > > >BPDCN (See Abbrev.) CANCER. *

---

Treat.: Tagraxofusp (Diphtheria Toxin-IL3 Fusion Protein)
EU Approval Date: 2021. 01.21.
USA Approval Date: 2018. 12.21.
USA Launch Date: ?
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2021. 02.18.


>BPDCN (See Abbrev.) CANCER. *'s products
This section has no products